2023

Host versus graft HLA-DP1 mismatching promotes graft versus host disease. Wright, C., Reid, G., Lendrem, B.C. et al. 2023. Bone Marrow Transplant . doi: 10.1038/s41409-023-02003-6.

2021

Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin. Batta K, Bossenbroek HM, Pemmaraju N, Wilks DP, Chasty R, Dennis M, Milne P, Collin M, Beird HC, Taylor J, Patnaik MM, Cargo CA, Somervaille TCP, Wiseman DH. Leukemia. 2021 Apr 8. doi: 10.1038/s41375-021-01228-y. Epub ahead of print. PMID: 33833384.

2020

Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans. Cytlak U, Resteu A, Pagan S, Green K, Milne P, Maisuria S, McDonald D, Hulme G, Filby A, Carpenter B, Queen R, Hambleton S, Hague R, Lango Allen H, Thaventhiran JED, Doody G, Collin M, Bigley V.  Immunity. 2020;53(2):353-370.e8. doi:10.1016/j.immuni.2020.07.003

Notch-mediated generation of monocyte-derived Langerhans cells: Phenotype and function Bellmann L, Zelle-Rieser C, Milne P, Resteu A, Tripp CH, Hermann- Kleiter N, Zaderer V, Wilflingseder D, Hörtnagl P, Theochari M, Schulze J, Rentzsch M, Del Frari B, Collin M, Rademacher C, Romani N, Stoitzner P, The Journal of Investigative Dermatology. 2020, doi: https:// doi.org/10.1016/j.jid.2020.05.098.

Insights from Patients with Dendritic Cell Immunodeficiency. Bigley V and Collin M. Molecular Immunology Volume 122, June 2020, Pages 116-123

Donor monocyte-derived macrophages promote human acute graft-versus-host disease. Jardine L, Cytlak U, Gunawan M, Reynolds G, Green K, Wang XN, Pagan S, Paramitha M, Lamb CA, Long AK, Hurst E, Nair S, Jackson GH, Publicover A, Bigley V, Haniffa M, Simpson AJ, Collin M. J Clin Invest. 2020 Sep 1;130(9):4574-4586. doi: 10.1172/JCI133909. PMID: 32453711; PMCID: PMC7456218.

2019

Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia. Milne  P, Wilhelm-Benartzi  C, Grunwald  MR,  Bigley V , Dillon  R,  Freeman  SD,  Gallagher  G, Publicover  A,  Pagan S, Marr H, Jones  GL, Dickinson  AM, Grech A , Burnett Ak , Russell  NH, Levis  M, Knapper  S, Collin M. Blood Adv (2019) 3 (20): 3052-3061.

2018

Notch signaling facilitates in vitro generation of cross-presenting classical dendritic cells. Kirkling ME, Cytlak U, Lau CM, Lewis KL, Resteu A, Khodadadi-Jamayran A, Siebel CW, Salmon H, Merad M, Tsirigos A, Collin M, Bigley V, Reizis B. Cell Reports 2018, 23(12), 3658-3672.e6. 

Ikaros family zinc finger 1 regulates dendritic cell development and function in humans. Cytlak U, Resteu A, Bogaert D, Kuehn HS, Altmann T, Gennery A, Jackson G, Kumanovics A, Voelkerding KV, Prader S, Dullaers M, Reichenbach J, Hill H, Haerynck F, Rosenzweig SD, Collin M, Bigley V. Nature Communications 2018, 9, 1239. 

Human dendritic cell immunodeficiencies. Bigley V, Cytlak U, Collin M.  Semin Cell Dev Biol. 2018 Feb 23. pii: S1084-9521(17) 30404-4  

Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation. Bigley V, Maisuria S, Cytlak U, Jardine L, Care MA, Green K, Gunawan M, Milne P, Dickinson R, Wiscombe S, Parry D, Doffinger R, Laurence A, Fonseca C, Stoevesandt O, Gennery A, Cant A, Tooze R, Simpson AJ, Hambleton S, Savic S, Doody G, Collin M.  Journal of Allergy and Clinical Immunology 2018, 141(6), 2234-2248.      

In vivo T-depleted reduced intensity transplantation for GATA2-related immune dysfunction. Tholouli E, Sturgess K, Dickinson RE, Gennery A, Cant AJ, Jackson G, Lordan J, Hambleton S, Slatter MA, Bigley V, Collin M.  Blood 2018 131:1383-1387

Human dendritic cell subsets: an update. Collin, M. & Bigley, V. Immunology. 10.1111/imm.12888. (2018)

A novel IKAROS haploinsufficiency kindred with unexpectedly late and variable B cell maturation defects. Bogaert, D. .J, Kuehn, H. S., Bonroy, C., Calvo, K. R., Dehoorne, J., Vanlander, A. V., De Bruyne, M., Cytlak, U., Bigley, V., De Baets, F., De Baere, E., Rosenzweig, S. D., Haerynck, F., Dullaers, M. J Allergy Clin Immunol. ;141(1):432-435.e7. (2018)

2017

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Milne, P., Bigley, V., Bacon, C. M., Néel, A., McGovern, N., Bomken, S., Haniffa, M., Diamond, E. L., Durham, B. H., Visser, J., Hunt, D., Gunawardena, H., Macheta, M., McClain, K. L., Allen. C., Abdel-Wahab, O., Collin, M. Blood, 130(2), 167–175. (2017)

Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation.  Bigley V., Maisuria S., Cytlak U., Jardine L., Care M. A., Green K., Gunawan M., Milne P., Dickinson R., Wiscombe S., Parry D., Doffinger R., Laurence A., Fonseca C., Stoevesandt O., Gennery A., Cant A., Tooze R., Simpson A. J., Hambleton S., Savic S., Doody G., Collin M. Journal of Allergy and Clinical Immunology. (2017). 

The Impact of Alemtuzumab Scheduling on Graft Versus Host Disease Following Unrelated Donor Fludarabine and Melphalan Allografts. Biology of Blood and Marrow Transplantation. Green, K.,  Pearce, K., Sellar, R., Jardine, L., Nicolson, P. L. R.,  Nagra, S., Bigley, V., & Jackson, G., & Dickinson, A., Thomson, K., Mackinnon, S., Craddock, C., Peggs, K. S, and Collin, M. 23. . 10.1016/j.bbmt.2017.02.007. (2017)

2016

Timely follow-up of a GATA2 deficiency patient allows successful treatment. Mannurita, S. C., Vignoli, M., Colarusso, G., Tucci, F., Veltroni, M., Frenos, S., Tintori, V., Arico, M., Bigley, V., Collin, M., and Gambineri, E. JACI in press. (2016)

The Mononuclear Phagocyte System in Organ Transplantation.  Ochando, J., Kwan, W. H., Ginhoux, F., Hutchinson, J. A., Hashimoto, D., and Collin, M. Am J Transplant 16, 1053-1069. (2016)

Single-gene association between GATA-2 and autoimmune hepatitis: A novel genetic insight highlighting immunologic pathways to disease. Webb, G., Chen, Y. Y., Li, K. K., Neil, D., Oo, Y. H., Richter, A., Bigley, V., Collin, M., Adams, D. H., and Hirschfield, G. M. J Hepatol (2016)

miR-146a and miR-155 Expression Levels in Acute Graft-Versus-Host Disease Incidence. Atarod, S., Ahmed, M. M., Lendrem, C., Pearce, K. F., Cope, W., Norden, J., Wang, X. N., Collin, M., and Dickinson, A. M. Front Immunol 7, 56. (2016)

Langerhans cell origin and regulation. Collin, M., and Milne, P. Curr Opin Hematol 23, 28-35. (2016)

Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci. Egeler, R. M., Katewa, S., Leenen, P. J., Beverley, P., Collin, M., Ginhoux, F., Arceci, R. J., and Rollins, B. J. Pediatr Blood Cancer 63, 1704-1712. (2016)

Granulocyte infusion: benefit beyond neutrophils? T., Jones, G. L., and Collin, M. Transfus Med (2016)

Dendritic Cells and Dendritic Cell Subsets. Collin, M., and Haniffa, M. In Encyclopedia of Immunobiology, eds. (Oxford: Academic Press), pp. 345-352. (2016)

2015

Predicting survival using clinical risk scores and non-HLA immunogenetics. Balavarca, Y., Pearce, K., Norden, J., Collin, M., Jackson, G., Holler, E., Dressel, R., Kolb, H. J., Greinix, H., Socie, G., Toubert, A., Rocha, V., Gluckman, E., Hromadnikova, I., Sedlacek, P., Wolff, D., Holtick, U., Dickinson, A., and Bickeboller, H. Bone Marrow Transplant 50, 1445-1452. (2015)

Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells. Bigley, V., McGovern, N., Milne, P., Dickinson, R., Pagan, S., Cookson, S., Haniffa, M., and Collin, M. J Leukoc Biol 97, 627-634. (2015)

Identification and validation of biomarkers associated with acute and chronic graft versus host disease. Ahmed, S. S., Wang, X. N., Norden, J., Pearce, K., El-Gezawy, E., Atarod, S., Hromadnikova, I., Collin, M., Holler, E., and Dickinson, A. M. Bone Marrow Transplant 50, 1563-1571. (2015)

Human mononuclear phagocyte system reunited. Haniffa, M., Bigley, V., and Collin, M. Semin Cell Dev Biol 41, 59-69. (2015)

Haematopoietic and immune defects associated with GATA2 mutation. Collin, M., Dickinson, R., and Bigley, V. Br J Haematol 169, 173-187. (2015)

Elevated level of HSPA1L mRNA correlates with graft-versus-host disease. Atarod, S., Turner, B., Pearce, K. F., Ahmed, S. S., Norden, J., Bogunia-Kubik, K., Wang, X. N., Collin, M., and Dickinson, A. M. Transpl Immunol 32, 188-194. (2015).

Cell(s) of Origin of Langerhans Cell Histiocytosis. Collin, M., Bigley, V., McClain, K. L., and Allen, C. E. Hematol Oncol Clin North Am 29, 825-838. (2015)

CD1c+ blood dendritic cells have Langerhans cell potential. Milne, P., Bigley, V., Gunawan, M., Haniffa, M., and Collin, M. Blood 125, 470-473. (2015)

Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy.  Halter, J. P., Michael, W., Schupbach, M., Mandel, H., Casali, C., Orchard, K., Collin, M.,  . . . and Hirano, M. Brain 138, 2847-2858. (2015)

A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants. Jardine, L., Publicover, A., Bigley, V., Hale, G., Pearce, K., Dickinson, A., Jackson, G., and Collin, M. Br J Haematol 168, 874-881. (2015)

2014

CD1c+blood dendritic cells have Langerhans cell potential. Milne P, Bigley V, Gunawan M, Haniffa M, Collin M. Blood. Oct 28 (2014) [Epub ahead of print]

Human dermal CD14⁺ cells are a transient population of monocyte-derived macrophages. McGovern N, Schlitzer A, Gunawan M, Jardine L, Shin A, Poyner E, Green K, Dickinson R, Wang XN, Low D, Best K, Covins S, Milne P, Pagan S, Aljefri K, Windebank M, Saavedra-Miranda, D, Larbi A, Wasan PS, Duan K, Poidinger M, Bigley V, Ginhoux F, Collin M, Haniffa M. Immunity. 41(3) 465-77 (2014)

BRAF-V600Eexpression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, Beltrão M, Lira SA, Heym KM, Bigley V, Collin M, Manz MG, McClain K, Merad M, Allen CE. J Exp Med. 211(4) 669-83. (2014)

The evolution of cellular deficiency in GATA2 mutation. Dickinson RE, Milne P, Jardine L, Zandi S, Swierczek SI, McGovern N, Cookson S, Ferozepurwalla Z, Langridge A, Pagan S, Gennery A, Heiskanen-Kosma T, Hämäläinen S, Seppänen M, Helbert M, Tholouli E, Gambineri E, Reykdal S, Gottfreðsson M, Thaventhiran JE, Morris E, Hirschfield G, Richter AG, Jolles S, Bacon CM, Hambleton S, Haniffa M, Bryceson, Y. Allen C, Prchal JT, Dick JE, Bigley V, Collin M. Blood 123(6) 863-74 (2014)

A question of persistence: Langerhans cells and graft versus host disease. Collin M, Jardine L. Exp Dermatol. Jan 21 (2014)

2013

Tumornecrosis factor-costimulated T lymphocytes from patients with systemicsclerosis trigger collagen production in fibroblasts. Hügle T, O'Reilly S, Simpson R, Kraaij MD, Bigley V, Collin M, Krippner-Heidenreich A, van Laar JM. Arthritis Rheum. 65(2) 481-91 (2013)

Rapid detection of dendritic cell and monocyte disorders using CD4 as a lineage marker of the human peripheral blood antigen-presenting cell compartment. Jardine L, Barge D, Ames-Draycott A, Pagan S, Cookson S, Spickett G, Haniffa M, Collin M, Bigley V. Front Immunol. 4:495 (2013)

A Three-Dimensional Atlas of Human Dermal Leukocytes, Lymphatics, and Blood Vessels. Wang XN, McGovern N, Gunawan M, Richardson C, Windebank M, Siah TW, Lim HY, Fink K, Li JL, Ng LG, Ginhoux F, Angeli V, Collin M, Haniffa M. J Invest Dermatol. Nov 11 (2013)

Ontogeny and functional specialization of dendritic cells in human and mouse. Haniffa M, Collin M, Ginhoux F. Adv Immunol.120:1-49 (2013)

Identification of human tissue cross-presenting dendritic cells: A new target for cancer vaccines. Haniffa M, Collin M, Ginhoux F. Oncoimmunology. 2(3) (2013)

IRF4 Transcription Factor-Dependent CD11b(+) Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses. Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, Ho AW, See P, Shin A, Wasan PS, Hoeffel G, Malleret B, Heiseke A, Chew S, Jardine L, Purvis HA, Hilkens CM, Tam J, Poidinger M, Stanley ER, Krug AB, Renia L, Sivasankar B, Ng LG, Collin M, Ricciardi-Castagnoli P, Honda K, Haniffa M, Ginhoux F. Immunity 38(5) 970-83 (2013)

Human Dendritic Cell Subsets. Collin M, McGovern N, Haniffa M. Immunology Apr 29 (2013)

Sensitizing primary acute lymphoblastic leukemia to natural killer cell recognition by induction of NKG2D ligands. Jardine L, Hambleton S, Bigley V, Pagan S, Wang XN, Collin M. Leuk Lymphoma 54(1) 167-73 (2013)

2012

Human Tissues Contain CD141(hi) Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103(+) Nonlymphoid Dendritic Cells. Haniffa M, Shin A, Bigley V, McGovern N, Teo P, See P, Wasan PS, Wang XN, Malinarich F, Malleret B, Larbi A, Tan P, Zhao H, Poidinger M, Pagan S, Cookson S, Dickinson R, Dimmick I, Jarrett RF, Renia L, Tam J, Song C, Connolly J, Chan JK, Gehring A, Bertoletti A, Collin M, Ginhoux F. Immunity 37(1) 60-73 (2012)

Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia Pearce KF, Lee SJ, Haagenson M, Petersdorf EW, Norden J, Collin MP, Klein JP, Spellman SR, Lowerson SA, Davies S, Dickinson AM. Haematologica. Jan 22 (2012)

Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design Teunissen MB, Haniffa M, Collin MP. Curr Top Microbiol Immunol 351, 25-76 (2012)

2011

Human dendritic cell deficiency: the missing ID? Collin, M., Bigley, V., Haniffa, M. & Hambleton, S. Nat Rev Immunol 11, 575-583 (2011).

Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome Bigley, V. & Collin, M. Haematologica 96, 1081-1083 (2011).

Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency Dickinson, R. E., Griffin, H., Bigley, V., Reynard, L. N., Hussain, R., Haniffa, M., Lakey, J. H., Rahman, T., Wang, X. N.,McGovern, N., Pagan, S., Cookson, S., McDonald, D., Chua, I., Wallis, J., Cant, A., Wright, M., Keavney,B.,Chinnery,P. F., Loughlin, J., Hambleton, S., Santibanez-Koref, M. & Collin, M. Blood 118, 2656-8 (2011).

Prognostic significance of interleukin-7 receptor-α gene polymorphisms in allogeneic stem-cell transplantation: a confirmatory study Shamim Z, Ryder LP, Christensen IJ, Toubert A, Norden J, Collin M, Jackson G, Dickinson AM, Müller K. Transplantation 91, 731-6 (2011). 

The involvement of epithelial fas in a human model of graft versus host disease Ruffin, N., Ahmed, S. S., Osorio, L. M., Wang, X. N., Jackson, G. H., Collin, M. P., Ekre, H. P., Chiodi, F. & Dickinson, A. M. Transplantation 91, 946-951 (2011).

The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. Bigley, V., Haniffa, M., Doulatov, S., Wang, X. N., Dickinson, R., McGovern, N., Jardine, L., Pagan, S., Dimmick, I., Chua, I., Wallis, J., Lordan, J., Morgan, C., Kumararatne, D. S., Doffinger, R., van der Burg, M., van Dongen, J., Cant, A.,Dick, J. E., Hambleton, S. & Collin, M. J Exp Med 208, 227-234 (2011).

IRF8 Mutations and Human Dendritic-Cell Immunodeficiency. Hambleton, S., Salem, S., Bustamante, J., Bigley, V., Boisson-Dupuis, S., Azevedo, J., Fortin, A., Haniffa, M., Ceron-Gutierrez, L., Bacon, C. M., Menon, G., Trouillet, C., McDonald, D., Carey, P., Ginhoux, F., Alsina, L., Zumwalt, T. J., ong,X. F., Kumararatne, D., Butler, K., Hubeau, M., Feinberg, J., Al-Muhsen, S., Cant, A., Abel, L., Chaussabel, D., Doffinger, R., Talesnik, E., Grumach, A., Duarte, A., Abarca, K., Moraes-Vasconcelos, D., Burk, D., Berghuis, A., Geissmann,F., Collin, M., Casanova, J. L. & Gros, P. N Engl J Med 365, 127-38 (2011).

2010 

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution. Chakraverty, R., Orti, G., Roughton, M., Shen, J., Fielding, A., Kottaridis, P., Milligan, D., Collin, M., Crawley, C., Johnson, P., Clark, A., Parker, A., Bloor, A., Pettengell, R., Snowden, J., Pettitt, A., Clark, R., Hale, G., Peggs, K., Thomson,K., Morris, E. & Mackinnon, S. Blood 116, 3080-3088 (2010).

Connecting the dots: monocyte/DC and NK subsets in human peripheral blood. Bigley, V., Spence, L. E. & Collin, M. Blood 116, 2859-2860 (2010).

Reduced intensity conditioning for hematopoietic stem cell transplantation: has it achieved all it set out to? Turner, B. E., Collin, M. & Rice, A. M. Cytotherapy 12, 440-454 (2010).

Comparison of gene expression profiles between human and mouse monocyte subsetsIngersoll, M. A., Spanbroek, R., Lottaz, C., Gautier, E. L., Frankenberger, M., Hoffmann, R., Lang, R., Haniffa, M., Collin, M., Tacke, F., Habenicht, A. J., Ziegler-Heitbrock, L. & Randolph, G. J. Blood 115, e10-9 (2010).

2009

Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML. Malladi, R. K., Peniket, A. J., Littlewood, T. J., Towlson, K. E., Pearce, R., Yin, J., Cavenagh, J. D., Craddock, C., Orchard, K. H., Olavarria, E., McQuaker, G., Collin, M. & Marks, D. I. Bone Marrow Transplant 43, 709-715 (2009).

Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming. Wang, X. N., Haniffa, M. A., Holtick, U., Collin, M. P., Jackson, G., Hilkens, C. M., Holler, E., Edinger, M., Hoffmann, P. & Dickinson, A. M. Transplantation 88, 188-197 (2009).

Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation. Haniffa, M., Ginhoux, F., Wang, X. N., Bigley, V., Abel, M., Dimmick, I., Bullock, S., Grisotto, M., Booth, T., Taub, P., Hilkens, C., Merad, M. & Collin, M. J Exp Med 206, 371-385 (2009).

Mesenchymal stem cells: the fibroblasts' new clothes? Haniffa,M. A., Collin, M. P., Buckley, C. D. & Dazzi, F. Haematologica 94, 258-263 (2009).

2008

Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses. Lopes, L., Dewannieux, M., Gileadi, U., Bailey, R., Ikeda, Y., Whittaker, C., Collin, M. P., Cerundolo, V., Tomihari, M., Ariizumi, K. & Collins, M. K. J Virol 82, 86-95 (2008).

Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells Merad, M., Ginhoux, F. & Collin, M. Nat Rev Immunol 8, 935-947 (2008).

2007 

Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state Ginhoux, F., Collin, M. P., Bogunovic, M., Abel, M., Leboeuf, M., Helft, J., Ochando, J., Kissenpfennig, A., Malissen, B., Grisotto, M., Snoeck, H., Randolph, G. & Merad, M. J Exp Med 204, 3133-3146 (2007).

Potent graft-versus-leukemia effect in BCR/ABL negative chronic myelogenous leukemia Holtick, U., Marshall, S. R., O'Brien, S. G. & Collin, M. P. Blood 110, 4622-4623 (2007) 

Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells Haniffa, M. A., Wang, X. N., Holtick, U., Rae, M., Isaacs, J. D., Dickinson, A. M., Hilkens, C. M. & Collin, M. P. J Immunol 179, 1595-1604 (2007).

Dendritic cell homeostasis and trafficking in transplantation Merad, M., Collin, M. & Bromberg, J. Trends Immunol 28, 353-359 (2007)

DC homeostasis in hematopoietic stem cell transplantation. Collin, M. P., Bogunovic, M. & Merad, M. Cytotherapy 9, 521-531 (2007).

2006

Impact of mismatching CD1a, a dimorphic antigen-presenting molecule, on graft-versus-host disease after hematopoietic stem cell transplantation. Lanning, E. M., Holtick, U., Dickinson, A. M., Holler, E., Gluckman, E., Hromadnikova, I., Middleton, P. G. & Collin, M. P. Transplantation 82, 1374-1376 (2006).

The fate of human Langerhans cells in hematopoietic stem cell transplantation. Collin, M. P., Hart, D. N., Jackson, G. H., Cook, G., Cavet, J., Mackinnon, S., Middleton, P. G. & Dickinson, A. M. J Exp Med 203, 27-33 (2006).

Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factors. Wang, X. N., Collin, M., Sviland, L., Marshall, S., Jackson, G., Schulz, U., Holler, E., Karrer, S., Greinix, H., Elahi, F., Hromadnikova, I. & Dickinson, A. M. Biol Blood Marrow Transplant 12, 152-159 (2006).

2005 

In vitro depletion of tissue-derived dendritic cells by CMRF-44 antibody and alemtuzumab: implications for the control of Graft-versus-host disease. Collin, M. P., Munster, D., Clark, G., Wang, X. N., Dickinson, A. M. & Hart, D. N. Transplantation 79, 722-725 (2005).